✦ LIBER ✦
Cost-effectiveness analysis of cetuximab/irinotecan vs active/best supportive care for the treatment of metastatic colorectal cancer patients who have failed previous chemotherapy treatment
✍ Scribed by Starling, N; Tilden, D; White, J; Cunningham, D
- Book ID
- 109999052
- Publisher
- Nature Publishing Group
- Year
- 2007
- Tongue
- English
- Weight
- 177 KB
- Volume
- 96
- Category
- Article
- ISSN
- 0007-0920
No coin nor oath required. For personal study only.